Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine

By sjmartinez • November 29, 2022

Edwards GG, Miyashita-Ochoa A, Castillo EG, Goodman-Meza D, Kalofonos I, Landovitz RJ, Leibowitz AA, Pulsipher C, El Sayed E, Shoptaw S, Shover CL, Tabajonda M, Yang YS, Harawa NT. Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine. AIDS Behav. 2022 Sep 5:1–15. doi: 10.1007/s10461-022-03817-z. Epub ahead of print. PMID: 36063243; PMCID: PMC9443641.

Tags: Addiction medicine, Antiretroviral medication, Cost, HIV treatment, Implementation barriers and facilitators, Infectious Diseases, Long acting injectable medication, Psychiatry, Publications

Advancing ethical biomedical HIV prevention research for pregnant and lactating people: a collaborative approach

Sullivan K, Chatani-Gada M, Lievense B, Slack C, Abrams E, Bunge K, Stranix-Chibanda L, Crawley FP, Das M, Joseph Davey D, Ghazaryan L, Hattas Y,[...]

A Murine Model of Dermatophytosis

Nabeela S, Agrawal N, Uppuluri P. A Murine Model of Dermatophytosis. Curr Protoc. 2026 Jan;6(1):e70287. doi: 10.1002/cpz1.70287. PMID: 41532249.

Clinical utility of serial plasma cell-free DNA metagenomic next-generation sequencing assays

Kaur I, Shaw B, Multani A, Malhotra S, Dong HV, Lukose C, Prabaker K, Saleh T, Sim YB, Tymchuk CN, Uslan DZ, Zhou H, Brewer[...]